What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery
NCT: NCT05823467 · TERMINATED
Brief Summary
This study will look at whether females who have previously had breast surgery and radiation and are undergoing repeat breast surgery require any post operative interventions. The reason the investigators are conducting this study is because females who have undergone breast radiation are at higher risk of wound complications following breast surgery. The investigators will randomize recruited female participants into three arms, one which is post operative antibiotics for one week, one which is a wound VAC, and one which is no intervention. The investigators goal is to identify whether these patients will require any postoperative interventions.
Frequently Asked Questions
What is What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery?
What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery is a clinical trial registered under NCT05823467. Current status: TERMINATED.
What is the status of NCT05823467?
The current status of NCT05823467 (What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery) is: TERMINATED.
When did What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery start?
What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery started on 2023-06-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.